NCT00033917View on ClinicalTrials.gov

Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

630

Participants

Timeline

Start Date

September 30, 1989

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Intraventricular Hemorrhage (IVH)Bleeding in the BrainPrematurityVery Low Birth Weight Infants
Interventions
DRUG

indomethacin

an anti-inflammatory drug

DRUG

placebo

saline

Trial Locations (3)

Unknown

Yale University School of Medicine, New Haven

Maine Medical Center, Portland

Brown University School of Medicine, Providence

All Listed Sponsors
lead

Yale University

OTHER